BC
CORV

Broadfin Capital’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Broadfin Capital’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-200,000
Closed -$1.58M – 88
2014
Q1 		$1.58M Buy
+200,000
New +$1.61M 0.15% 82

Other funds holding CORV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FIG
Fortress Investment Group New York $531M AUM 12.95% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
ACM
Alistair Capital Management Dallas, Texas $391M AUM 5.89% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Broadfin Capital's CORV Position: Q2 2014 in Review

Broadfin Capital sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2014, closing a stake of 200,000 shares — an estimated $1.58M sold.

Broadfin Capital first reported a position in CORV in Q1 2014 and held it in 1 quarter. The position peaked at $1.58M in Q1 2014. 32 funds tracked by Wall St. Rank hold CORV as of Q2 2014.

  • Broadfin Capital reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2014 after selling out during the quarter.
  • Broadfin Capital sold 200,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2014, an estimated $1.58M.
  • Broadfin Capital first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2014 and held it in 1 quarter.
  • Broadfin Capital's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $1.58M in Q1 2014.
  • 32 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2014.

Based on Broadfin Capital's 13F filing for Q2 2014, filed 14 Aug 2014.